Home › Companies › Iovance Biotherapeutics, Inc.
How asset managers voted at Iovance Biotherapeutics, Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.
| Season | Filed as | Ballot items | Asset managers |
|---|---|---|---|
| 2025-2026 | Iovance Biotherapeutics, Inc. | 13 | 226 |
| 2024-2025 | Iovance Biotherapeutics, Inc. | 11 | 259 |
| 2023-2024 | IOVANCE BIOTHERAPEUTICS INC. | 11 | 270 |
Earlier seasons list this company under the name IOVANCE BIOTHERAPEUTICS INC., as its holders filed it.
Explore Iovance Biotherapeutics, Inc. in the interactive database
The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. Ticker as listed by the SEC on October 13, 2026. This page is rebuilt weekly; built October 14, 2026.